Cyclopharm Limited
ASX:CYC
$ 1.65
$-0.02 (-1.20%)
$ 1.65
$-0.02 (-1.20%)
End-of-day quote: 05/16/2024

Cyclopharm financials at a glance

The revenue of Cyclopharm is reported as 0.02634 billion Dollars in the fiscal year 2023. The earnings were -0.07 Dollars per share in 2023, which was 40 lower than 2022. And about -0.00761 billion Dollars are reported as free cash flow in the financials of Cyclopharm 2023. No dividends were paid to the shareholders of the Cyclopharm stock ASX:CYC in the financial year 2023.

$26.34M
Revenue
$-0.07
Earnings Per Share
62.21%
Gross Margin %
$-8.10M
Free Cash Flow
Revenue
26.34
Earnings Per Share
-0.07
Gross Margin %
62.21
Free Cash Flow
-8.10

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015
Rev. Revenue N/A $26.34M $23.22M $17.70M $14.68M $14.08M $13.40M $13.19M $0.00M $0.00M
GM % Gross Margin % 67.70% 62.21% 70.06% 74.97% 77.58% 82.90% 80.90% 83.01% 76.35% 78.77%
OM Operating Margin -24.74% -33.99% -24.13% -21.14% -28.23% -17.38% -2.72% 6.50% 12.80% 16.65%
EPS Earnings Per Share $-0.08 $-0.07 $-0.05 $-0.04 $-0.06 $-0.03 $-0.00 $-0.02 $0.01 $0.06
Div. Dividends N/A $0.01 $0.01 $0.01 $0.01 $0.01 $0.00 $0.01 $0.00 $0.00
PR % Payout Ratio % 0 -14.29% -20.00% -25.00% -16.67% -33.33% 0 -50.00% 0 0
Sha. Shares N/AM 94.1M 93.05M 93.37M 93.37M 78.24M 68.7M 68.25M 59.73M 59.59M
OCF Operating Cash Flow N/A $-7.40M $0.00M $-1.63M $-8.93M $-0.49M $0.00M $-0.28M $0.00M $0.00M
FCF Free Cash Flow N/A $-8.10M $-1.80M $-2.47M $-9.47M $-0.97M $0.00M $-0.92M $0.00M $0.00M
FCFS Free Cash Flow Per Share $-0.08 $-0.08 $-0.09 $-0.03 $-0.12 $-0.01 $-0.03 $-0.03 $-0.03 $0.07